The content, links, and pdfs are no longer maintained and might be outdated.
- The content on this page is being archived for historic and reference purposes only.
- For current, updated information see the MMWR website.
Errata: Vol. 61, No. RR-4
In the MMWR Recommendations and Reports, "Recommendations for the Identification of Chronic Hepatitis C Infection Among Persons Born During 1945–1965," two errors occurred on page 10. Under the heading "All-Cause Mortality," 10 lines from the bottom, the parenthetical wording should read: "(Genotype 1 only: relative risk [RR] = 0.7; 95% CI = 0.59–0.83)." The original text erroneously presented the results from a post-hoc pooled analysis conducted by CDC. The correction reflects the findings of the cited study.
Under the heading "Sustained Virologic Response," the third sentence should read: "Newer direct-acting antiviral agents increase the chance of SVR from an average of 41.3% for pegylated interferon and ribavirin therapy to approximately 70% with triple therapy (pooled risk difference: 28%; 95% CI = 24%–32%)." The original text erroneously presented the findings of the cited studies as a relative risk. This correction accurately describes the findings as a pooled risk difference.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to firstname.lastname@example.org.